Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “antibiotics”

43 pharma patents match "antibiotics" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 43
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 43 pharmaceutical patents matching "antibiotics" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

43 results for “antibiotics” · 30,257 patents in full index Clear search

  1. US 7612037

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted

  2. US 7601690

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted

  3. US 7553962

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

  4. US 7521414

    Polyol macrolide antitumor-antibiotics from the marine actinomycete strain CNQ140

    The Regents of the University of California · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  5. US 7405199

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  6. US 7341993

    Cross-linked glycopeptide—cephalosporin antibiotics

    Theravance, Inc. · Granted Mar 11, 2008 · Expires Mar 6, 2028

    granted

  7. US 7332471

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted

  8. US 7331920

    Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted

  9. US 7279458

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Oct 9, 2007 · Expires Oct 4, 2027

    granted

  10. US 7179794

    Multivalent macrolide antibiotics

    Theravance, Inc. · Granted Feb 20, 2007 · Expires Feb 15, 2027

    granted

  11. US 7067482

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted

  12. US 7067481

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jun 27, 2006 · Expires Jun 22, 2026

    granted

  13. US 6995138

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Feb 7, 2006 · Expires Feb 2, 2026

    expired

  14. US 6974797

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Dec 13, 2005 · Expires Dec 8, 2025

    expired

  15. US 6878686

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Apr 12, 2005 · Expires Apr 7, 2025

    expired

  16. US 6723716

    7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof

    Essential Therapeutics, Inc. · Granted Apr 20, 2004 · Expires Apr 15, 2024

    expired

  17. US 6599893

    Cephalosporin antibiotics and prodrugs thereof

    Essential Therapeutics, Inc. · Granted Jul 29, 2003 · Expires Jul 24, 2023

    expired

  18. US 6566509

    Multivalent macrolide antibiotics

    Theravance, Inc. · Granted May 20, 2003 · Expires May 15, 2023

    expired

  19. US 6518243

    Desleucyl glycopeptide antibiotics and methods of making same

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 11, 2003 · Expires Feb 6, 2023

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.